Tag results
Trials tagged with: "revlimid"
A Phase 3, multicentre, randomised, double blind, placebo controlled, parallel group study to compare the efficacy and safety of lenalidomide (Revlimid®) versus placebo in subjects with transfusion dependent anaemia due to IPSS low or intermediate-1 risk myelodysplastic syndromes without deletion 5Q [31] and unresponsive or refractory to erythropoiesis stimulating agents.
A Phase 2, Multi-Center, Randomized, Double-Blind, Parallel-Group Study Of The Safety And Efficacy Of Different Lenalidomide (Revlimid®) Dose Regimens In Subjects With Relapsed Or Refractory B-Cell Chronic Lymphocytic Leukemia.